Increased expression of CCAAT/enhancer binding protein β correlates with prognosis in glioma patients

Oncology Reports

Volumn 15, Issue 3, 2006, Pages 595-601

  Homma, Jumpei ^a   Yamanaka, Ryuya ^a   Yajima, Naoki ^a   Tsuchiya, Naoto ^a   Genkai, Nobuyuki ^a   Sano, Masakazu ^a   Tanaka, Ryuichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

CCAAT enhancer binding protein ; Glioma; Interleukin 8; siRNA

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; INTERLEUKIN 8; MESSENGER RNA; SMALL INTERFERING RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELL MOTION; CELL PROLIFERATION; CHILD; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; GLIOBLASTOMA; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SECRETION; SURVIVAL; TUMOR CELL LINE;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHILD; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS; TRANSFECTION;

EID: 33645732616     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.3.595     Document Type: Article

References (41)

1. Karpeh MS, Kelsen DP and Tepper JE: Cancer of the stomach. In: Cancer, Principles and Practice of Oncology. 6th edition. Devita VT Jr (ed). Lippincott Williams & Wilkins, Philadelphia, pp1092-1121, 2001.
2. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359: 1011-1018, 2002.
3. Yamanaka R, Lekstrom-Himes J, Barlow C, Wynshaw-Boris A and Xanthopoulos KG: CCAAT/enhancer binding proteins are critical components of the transcriptional regulation of hematopoiesis (Review). Int J Mol Med 1: 213-221, 1998.
4. Williams SC, Cantwell CA and Johnson PF: A family of C/ EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro . Genes Dev 5: 1553-1567, 1991. (Pubitemid 21906061)
5. Stein B, Cogswell PC and Baldwin AS Jr: Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol Cell Biol 13: 3964-3974, 1993. (Pubitemid 23187624)
6. Landschulz WH, Johnson PF, Adashi EY, Graves BJ and McKnight SL: Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev 2: 786-800, 1988.
7. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR and Darlington GJ: Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269: 1108-1112, 1995.
8. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T and Kishimoto T: A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9: 1897-1906, 1990.
9. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, Shirafuji N, Fujiwara H, Suematsu S, Yoshida N and Kishimoto T: Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80: 353-361, 1995.
10. Roman C, Platero JS, Shuman J and Calame K: Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP. Genes Dev 4: 1404-1415, 1990.
11. Cao Z, Umek RM and McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5: 1538-1552, 1991. (Pubitemid 21906060)
12. Yamanaka R, Kim GD, Radomska HS, Lekstrom-Himes J, Smith LT, Antonson P, Tenen DG and Xanthopoulos KG: CCAAT/enhancer binding protein epsilon is preferentially upregulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci USA 94: 6462-6467, 1997.
13. Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla LH, Liu PP, Eckhaus M, Decker T, Wynshaw-Boris A and Xanthopoulos KG: Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci USA 94: 13187-13192, 1997. (Pubitemid 27518497)
14. Ron D and Habener JF: CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6: 439-453, 1992.
15. Cortes-Canteli M, Pignatelli M, Santos A and Perez-Castillo A: CCAAT/enhancer-binding protein beta plays a regulatory role in differentiation and apoptosis of neuroblastoma cells. J Biol Chem 277: 5460-5467, 2002. (Pubitemid 34968595)
16. Kinoshita S, Akira S and Kishimoto T: A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc Natl Acad Sci USA 89: 1473-1476, 1992.
17. Ossipow V, Descombes P and Schibler U: CCAAT/enhancerbinding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci USA 90: 8219-8223, 1993. (Pubitemid 23260887)
18. Descombes P, Chojkier M, Lichtsteiner S, Falvey E and Schibler U: LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev 4: 1541-1551, 1990.
19. Osada S, Yamamoto H, Nishihara T and Imagawa M: DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. J Biol Chem 271: 3891-3896, 1996. (Pubitemid 26065711)
20. Akira S and Kishimoto T: NF-IL6 and NF-kappa B in cytokine gene regulation. Adv Immunol 65: 1-46, 1997.
21. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T and Akira S: Transcription factors NF-IL6 and NFkappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90: 10193-10197, 1993. (Pubitemid 23328278)
22. Pope RM, Leutz A and Ness SA: C/EBP beta regulation of the tumor necrosis factor alpha gene. J Clin Invest 94: 1449-1455, 1994.
23. Yamanaka R, Tanaka R, Saitoh T and Okoshi S: Cytokine gene expression on glioma cell lines and specimens. J Neurooncol 21: 243-247, 1994. (Pubitemid 24381473)
24. Zahnow CA, Younes P, Laucirica R and Rosen JM: Overexpression of C/EBPbeta-LIP, a naturally occurring, dominantnegative transcription factor, in human breast cancer. J Natl Cancer Inst 89: 1887-1891, 1997. (Pubitemid 28009825)
25. Sundfeldt K, Ivarsson K, Carlsson M, Enerback S, Janson PO, Brannstrom M and Hedin L: The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPbeta during epithelial tumour progression. Br J Cancer 79: 1240-1248, 1999. (Pubitemid 29087905)
26. Rask K, Thorn M, Ponten F, Kraaz W, Sundfeldt K, Hedin L and Enerback S: Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBP beta) and C/ EBPzeta (CHOP) correlate with invasiveness of human colorectal cancer. Int J Cancer 86: 337-343, 2000. (Pubitemid 30187493)
27. Oya M, Horiguchi A, Mizuno R, Marumo K and Murai M: Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma. Clin Cancer Res 9: 1021-1027, 2003. (Pubitemid 36323706)
28. Oh HS and Smart RC: Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms. J Invest Dermatol 110: 939-945, 1998.
29. Tomizawa M, Saisho H and Tagawa M: Regulatory regions of growth-related genes can activate an exogenous gene of the alpha-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells. Anticancer Res 23: 3273-3277, 2003. (Pubitemid 36975423)
30. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC and Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215-225, 2002. (Pubitemid 34212595)
31. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK and De Pinho RA: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333, 2001. (Pubitemid 32524640)
32. Bostrom PJ, Ravanti L, Reunanen N, Aaltonen V, Soderstrom KO, Kahari VM and Laato M: Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer 88: 417-423, 2000.
33. Hofmann A, Laue S, Rost AK, Scherbaum WA and Aust G: mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. Thyroid 8: 203-214, 1998. (Pubitemid 28145183)
34. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA and Dinney CP: Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 6: 2104-2119, 2000. (Pubitemid 30305111)
35. De Clerck YA, Shimada H, Taylor SM and Langley KE: Matrix metalloproteinases and their inhibitors in tumor progression. Ann NY Acad Sci 732: 222-232, 1994.
36. Jeffrey JJ: Regulation of Matrix Accumulation. Mecham RP (ed). Academic Press, New York, pp53-98, 1986.
37. Qin H, Sun Y and Benveniste EN: The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metallo-proteinase- 2 gene expression in astroglioma cells. J Biol Chem 274: 29130-29137, 1999.
38. Doyle GA, Pierce RA and Parks WC: Transcriptional induction of collagenase-1 in differentiated monocyte-like (U937) cells is regulated by AP-1 and an upstream C/EBP-beta site. J Biol Chem 272: 11840-11849, 1997. (Pubitemid 27202753)
39. Vegesna V, Takeuchi S, Hofmann WK, Ikezoe T, Tavor S, Krug U, Fermin AC, Heaney A, Miller CW and Koeffler HP: C/EBP-beta, C/EBP-delta, PU.1, AML1 genes: mutational analysis in 381 samples of hematopoietic and solid malignancies. Leuk Res 26: 451-457, 2002. (Pubitemid 34251089)
40. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W and Tenen DG: Dominantnegative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27: 263-270, 2001. (Pubitemid 32201846)
41. Zhu S, Yoon K, Sterneck E, Johnson PF and Smart RC: CCAAT/ enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc Natl Acad Sci USA 99: 207-212, 2002. (Pubitemid 34060342)